Artigos de revistas sobre o tema "Preclinical tumor models"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Preclinical tumor models".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Varticovski, L., M. G. Hollingshead, M. R. Anver, A. I. Robles, J. E. Green, K. W. Hunter, G. Merlino et al. "Preclinical testing using tumors from genetically engineered mouse mammary models". Journal of Clinical Oncology 24, n.º 18_suppl (20 de junho de 2006): 10067. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.10067.
Texto completo da fonteKlenner, Marbod, Pia Freidel, Mariella G. Filbin e Alexander Beck. "DIPG-39. New preclinical models for Diffuse Midline Glioma". Neuro-Oncology 24, Supplement_1 (1 de junho de 2022): i27. http://dx.doi.org/10.1093/neuonc/noac079.096.
Texto completo da fonteCosta, Alice, Livia Gozzellino, Margherita Nannini, Annalisa Astolfi, Maria Abbondanza Pantaleo e Gianandrea Pasquinelli. "Preclinical Models of Visceral Sarcomas". Biomolecules 13, n.º 11 (6 de novembro de 2023): 1624. http://dx.doi.org/10.3390/biom13111624.
Texto completo da fonteLlaguno-Munive, Monserrat, Wilberto Villalba-Abascal, Alejandro Avilés-Salas e Patricia Garcia-Lopez. "Near-Infrared Fluorescence Imaging in Preclinical Models of Glioblastoma". Journal of Imaging 9, n.º 10 (6 de outubro de 2023): 212. http://dx.doi.org/10.3390/jimaging9100212.
Texto completo da fonteSewduth, Raj N., e Konstantina Georgelou. "Relevance of Carcinogen-Induced Preclinical Cancer Models". Journal of Xenobiotics 14, n.º 1 (5 de janeiro de 2024): 96–109. http://dx.doi.org/10.3390/jox14010006.
Texto completo da fonteRoosen, Mieke, Chris Meulenbroeks, Phylicia Stathi, Joris Maas, Julie Morscio, Jens Bunt e Marcel Kool. "BIOL-11. PRECLINICAL MODELLING OF PEDIATRIC BRAIN TUMORS USING ORGANOID TECHNOLOGY". Neuro-Oncology 25, Supplement_1 (1 de junho de 2023): i8. http://dx.doi.org/10.1093/neuonc/noad073.030.
Texto completo da fonteStripay, Jennifer L., Thomas E. Merchant, Martine F. Roussel e Christopher L. Tinkle. "Preclinical Models of Craniospinal Irradiation for Medulloblastoma". Cancers 12, n.º 1 (5 de janeiro de 2020): 133. http://dx.doi.org/10.3390/cancers12010133.
Texto completo da fonteSitta, Juliana, Pier Paolo Claudio e Candace M. Howard. "Virus-Based Immuno-Oncology Models". Biomedicines 10, n.º 6 (18 de junho de 2022): 1441. http://dx.doi.org/10.3390/biomedicines10061441.
Texto completo da fonteOrtiz, Michael Vincent, Armaan Siddiquee, Daoqi You, Prabhjot Singh Mundi, Lianna Marks, Kristina Guillan, Daniel Diolaiti et al. "Preclinical evaluation of XPO1 inhibition in Wilms tumors." Journal of Clinical Oncology 38, n.º 15_suppl (20 de maio de 2020): 3580. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.3580.
Texto completo da fonteBella, Ángela, Claudia Augusta Di Trani, Myriam Fernández-Sendin, Leire Arrizabalaga, Assunta Cirella, Álvaro Teijeira, José Medina-Echeverz, Ignacio Melero, Pedro Berraondo e Fernando Aranda. "Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications". Cancers 13, n.º 5 (25 de fevereiro de 2021): 963. http://dx.doi.org/10.3390/cancers13050963.
Texto completo da fonteMahmoudian, Reihaneh Alsadat, Moein Farshchian, Fatemeh Fardi Golyan, Parvaneh Mahmoudian, Ali Alasti, Vahid Moghimi, Mina Maftooh et al. "Preclinical tumor mouse models for studying esophageal cancer". Critical Reviews in Oncology/Hematology 189 (setembro de 2023): 104068. http://dx.doi.org/10.1016/j.critrevonc.2023.104068.
Texto completo da fonteTada, Takuya, Thomas D. Norton, Rebecca Leibowitz e Nathaniel R. Landau. "Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models". Journal for ImmunoTherapy of Cancer 12, n.º 4 (abril de 2024): e008761. http://dx.doi.org/10.1136/jitc-2023-008761.
Texto completo da fonteBaniahmad, Aria. "Tumor spheroids and organoids as preclinical model systems". Medizinische Genetik 33, n.º 3 (1 de setembro de 2021): 229–34. http://dx.doi.org/10.1515/medgen-2021-2093.
Texto completo da fonteTellez-Gabriel, Marta, Denis Cochonneau, Marie Cadé, Camille Jubelin, Marie-Françoise Heymann e Dominique Heymann. "Circulating Tumor Cell-Derived Pre-Clinical Models for Personalized Medicine". Cancers 11, n.º 1 (24 de dezembro de 2018): 19. http://dx.doi.org/10.3390/cancers11010019.
Texto completo da fonteEhrenberg, Karl Roland, Jianpeng Gao, Felix Oppel, Stephanie Frank, Na Kang, Sebastian M. Dieter, Friederike Herbst et al. "Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer". Cells 8, n.º 2 (10 de fevereiro de 2019): 142. http://dx.doi.org/10.3390/cells8020142.
Texto completo da fontePinto, Bárbara, Ana C. Henriques, Patrícia M. A. Silva e Hassan Bousbaa. "Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research". Pharmaceutics 12, n.º 12 (6 de dezembro de 2020): 1186. http://dx.doi.org/10.3390/pharmaceutics12121186.
Texto completo da fonteDavy, Mélodie, Laurie Genest, Christophe Legrand, Océane Pelouin, Guillaume Froget, Vincent Castagné e Tristan Rupp. "Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models". Cancers 15, n.º 18 (8 de setembro de 2023): 4478. http://dx.doi.org/10.3390/cancers15184478.
Texto completo da fonteKoptyra, Mateusz, Valerie Baubet, David Beale, Luke Patterson, Ian Biluck, Madison Hollawell, Christopher M. Beck et al. "MODL-30. Children’s Brain Tumor Network preclinical tumor models development and sharing platform: collaborative model empowering pediatric brain tumor discovery and global research." Neuro-Oncology 24, Supplement_1 (1 de junho de 2022): i175—i176. http://dx.doi.org/10.1093/neuonc/noac079.653.
Texto completo da fonteMohr, Hermine, e Natalia S. Pellegata. "Animal models of MEN1". Endocrine-Related Cancer 24, n.º 10 (outubro de 2017): T161—T177. http://dx.doi.org/10.1530/erc-17-0249.
Texto completo da fonteMinami, Jenna, Nicholas Bayley, Christopher Tse, Henan Zhu, Danielle Morrow, William Yong, Linda Liau, Timothy Cloughesy, Thomas Graeber e David Nathanson. "TAMI-06. PRECLINICAL MODELS REVEAL BRAIN-MICROENVIRONMENT SPECIFIC METABOLIC DEPENDENCIES IN GLIOBLASTOMA". Neuro-Oncology 22, Supplement_2 (novembro de 2020): ii214. http://dx.doi.org/10.1093/neuonc/noaa215.895.
Texto completo da fonteHollawell, Madison, Valerie Baubet, David Beale, Luke Patterson, Ian Biluck, Ciana Anthony, Peeyush Goel et al. "BIOL-22. CHILDREN’S BRAIN TUMOR NETWORK PRECLINICAL TUMOR MODELS DEVELOPMENT AND SHARING PLATFORM: COLLABORATIVE MODEL EMPOWERING PEDIATRIC BRAIN TUMOR DISCOVERY AND GLOBAL RESEARCH". Neuro-Oncology 25, Supplement_1 (1 de junho de 2023): i10—i11. http://dx.doi.org/10.1093/neuonc/noad073.041.
Texto completo da fonteHansson, Karin, Katarzyna Radke, Kristina Aaltonen, Jani Saarela, Adriana Mañas, Jonas Sjölund, Emma M. Smith et al. "Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma". Science Translational Medicine 12, n.º 562 (23 de setembro de 2020): eaba4434. http://dx.doi.org/10.1126/scitranslmed.aba4434.
Texto completo da fonteMinami, Jenna, Nicholas Bayley, Christopher Tse, Henan Zhu, Danielle Morrow, William Yong, Linda Liau, Timothy F. Cloughesy, Thomas Graeber e David A. Nathanson. "ETMM-02. PRECLINICAL MODELS REVEAL BRAIN-MICROENVIRONMENT SPECIFIC METABOLIC DEPENDENCIES IN GLIOBLASTOMA". Neuro-Oncology Advances 3, Supplement_1 (1 de março de 2021): i14. http://dx.doi.org/10.1093/noajnl/vdab024.058.
Texto completo da fonteSgouros, George, Robert F. Hobbs e Diane S. Abou. "The Role of Preclinical Models in Radiopharmaceutical Therapy". American Society of Clinical Oncology Educational Book, n.º 34 (maio de 2014): e121-e125. http://dx.doi.org/10.14694/edbook_am.2014.34.e121.
Texto completo da fonteDobson, Tara, e Vidya Gopalakrishnan. "Preclinical Models of Pediatric Brain Tumors—Forging Ahead". Bioengineering 5, n.º 4 (2 de outubro de 2018): 81. http://dx.doi.org/10.3390/bioengineering5040081.
Texto completo da fonteForde, Patrick F., Mira Sadadcharam, Michael G. Bourke, Thomas A. Conway, Shane R. Guerin, Marcel de Kruijf, Gerald C. O’Sullivan, Joseph Impellizeri, Anthony J. P. Clover e Declan M. Soden. "Preclinical evaluation of an endoscopic electroporation system". Endoscopy 48, n.º 05 (4 de abril de 2016): 477–83. http://dx.doi.org/10.1055/s-0042-101343.
Texto completo da fonteChen, Stephen R., Frederick F. Lang e Peter Kan. "Preclinical animal brain tumor models for interventional neuro-oncology". Journal of NeuroInterventional Surgery 14, n.º 5 (12 de abril de 2022): neurintsurg—2022–018968. http://dx.doi.org/10.1136/neurintsurg-2022-018968.
Texto completo da fonteWu, Jianrong, e Peter J. Houghton. "Assessing Cytotoxic Treatment Effects in Preclinical Tumor Xenograft Models". Journal of Biopharmaceutical Statistics 19, n.º 5 (7 de agosto de 2009): 755–62. http://dx.doi.org/10.1080/10543400903105158.
Texto completo da fonteBanerjee, Sulagna, Venugopal Thayanithy, Veena Sangwan, Tiffany N. Mackenzie, Ashok K. Saluja e Subbaya Subramanian. "Minnelide reduces tumor burden in preclinical models of osteosarcoma". Cancer Letters 335, n.º 2 (julho de 2013): 412–20. http://dx.doi.org/10.1016/j.canlet.2013.02.050.
Texto completo da fonteVitale, Giovanni, Silvia Carra, Ylenia Alessi, Federica Campolo, Carla Pandozzi, Isabella Zanata, Annamaria Colao e Antongiulio Faggiano. "Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies". International Journal of Molecular Sciences 24, n.º 4 (10 de fevereiro de 2023): 3610. http://dx.doi.org/10.3390/ijms24043610.
Texto completo da fonteMcCloskey, Curtis, Galaxia Rodriguez, Kristianne Galpin e Barbara Vanderhyden. "Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics". Cancers 10, n.º 8 (26 de julho de 2018): 244. http://dx.doi.org/10.3390/cancers10080244.
Texto completo da fonteDondossola, Eleonora, Andrey S. Dobroff, Serena Marchiò, Marina Cardó-Vila, Hitomi Hosoya, Steven K. Libutti, Angelo Corti, Richard L. Sidman, Wadih Arap e Renata Pasqualini. "Self-targeting of TNF-releasing cancer cells in preclinical models of primary and metastatic tumors". Proceedings of the National Academy of Sciences 113, n.º 8 (8 de fevereiro de 2016): 2223–28. http://dx.doi.org/10.1073/pnas.1525697113.
Texto completo da fonteHicks, William H., Cylaina E. Bird, Jeffrey I. Traylor, Diana D. Shi, Tarek Y. El Ahmadieh, Timothy E. Richardson, Samuel K. McBrayer e Kalil G. Abdullah. "Contemporary Mouse Models in Glioma Research". Cells 10, n.º 3 (23 de março de 2021): 712. http://dx.doi.org/10.3390/cells10030712.
Texto completo da fonteErnst, Kati, Konstantin Okonechnikov, Laura von Soosten, Nina Hofmann, Norman Mack, Benjamin Schwalm, Robert J. Wechsler-Reya et al. "BIOL-07. DISTINCTIVE FEATURES OF HIGH-GRADE GLIOMA MOUSE MODELS REVEALED BY SINGLE-NUCLEUS RNA-SEQUENCING GUIDE PRE-CLINICAL MODEL SELECTION". Neuro-Oncology 25, Supplement_1 (1 de junho de 2023): i7. http://dx.doi.org/10.1093/neuonc/noad073.026.
Texto completo da fonteChauhan, Aman, Piotr Rychahou, Tadahide Izumi, Susanne M. Arnold, Lowell Brian Anthony, Mark Evers e Charles Kunos. "Antitumor efficacy of M3814 as a radiation sensitizer in neuroendocrine tumor (NET) preclinical models." Journal of Clinical Oncology 37, n.º 15_suppl (20 de maio de 2019): e15699-e15699. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e15699.
Texto completo da fonteHaskell-Mendoza, Aden, Lucas Wachsmuth e Peter Fecci. "LMAP-09 RECAPITULATING LASER INTERSTITIAL THERMAL THERAPY IN PRECLINICAL BRAIN TUMOR MODELS". Neuro-Oncology Advances 5, Supplement_3 (1 de agosto de 2023): iii11. http://dx.doi.org/10.1093/noajnl/vdad070.040.
Texto completo da fonteLee, Jung Woo, Jia Kim, Youngjae Shin, Byung Hoon Chi, Jung Hoon Kim e Se Young Choi. "Patient-Specific Tumor Microenvironment Models". Korean Journal of Urological Oncology 19, n.º 4 (30 de novembro de 2021): 197–222. http://dx.doi.org/10.22465/kjuo.2021.19.4.197.
Texto completo da fonteKalra, Jessica, Jennifer Baker, Justin Song, Alastair Kyle, Andrew Minchinton e Marcel Bally. "Inter-Metastatic Heterogeneity of Tumor Marker Expression and Microenvironment Architecture in a Preclinical Cancer Model". International Journal of Molecular Sciences 22, n.º 12 (13 de junho de 2021): 6336. http://dx.doi.org/10.3390/ijms22126336.
Texto completo da fonteSpoormans, Kaat, Melissa Crabbé, Lara Struelens, Marijke De Saint-Hubert e Michel Koole. "A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT)". Pharmaceutics 14, n.º 10 (22 de setembro de 2022): 2007. http://dx.doi.org/10.3390/pharmaceutics14102007.
Texto completo da fonteBarachini, Serena, Mariangela Morelli, Orazio Santo Santonocito e Chiara Maria Mazzanti. "Preclinical glioma models in neuro-oncology: enhancing translational research". Current Opinion in Oncology 35, n.º 6 (1 de setembro de 2023): 536–42. http://dx.doi.org/10.1097/cco.0000000000000997.
Texto completo da fonteKemper, Kristel, Ellis Gielen, Peter Boross, Mischa Houtkamp, Theo S. Plantinga, Stefanie AH de Poot, Saskia M. Burm et al. "Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 in preclinical tumor models". Life Science Alliance 5, n.º 11 (8 de setembro de 2022): e202201481. http://dx.doi.org/10.26508/lsa.202201481.
Texto completo da fonteGolebiewska, Anna, Ann-Christin Hau, Anais Oudin, Daniel Stieber, Yahaya A. Yabo, Yong-Jun Kwon, Barbara Klink et al. "TMOD-08. PRIMARY AND RECURRENT GLIOMA PATIENT-DERIVED ORTHOTOPIC XENOGRAFTS (PDOX) REPRESENT RELEVANT PATIENT AVATARS FOR PRECISION MEDICINE". Neuro-Oncology 22, Supplement_2 (novembro de 2020): ii229. http://dx.doi.org/10.1093/neuonc/noaa215.959.
Texto completo da fonteYu, Rong, Ewetse Paul Maswikiti, Yang Yu, Lei Gao, Chenhui Ma, Huanhuan Ma, Xiaobo Deng, Na Wang, Bofang Wang e Hao Chen. "Advances in the Application of Preclinical Models in Photodynamic Therapy for Tumor: A Narrative Review". Pharmaceutics 15, n.º 1 (5 de janeiro de 2023): 197. http://dx.doi.org/10.3390/pharmaceutics15010197.
Texto completo da fonteSaito, Yasuyuki, Afroj Tania, Satomi Komori, Tomoko Takai, Okechi S. Oduori, Takenori Kotani, Yohei Funakoshi et al. "Preclinical Evaluation of the Efficacy of Human Sirpα Antibodies for B-Cell Lymphoma Immunotherapy in Humanized Mouse Models". Blood 142, Supplement 1 (28 de novembro de 2023): 1646. http://dx.doi.org/10.1182/blood-2023-181926.
Texto completo da fonteZhu, Menghan, Nan Jia, Yanyan Nie, Jun Chen, Yahui Jiang, Tianjiao Lv, Yuanyuan Li, Liangqing Yao e Weiwei Feng. "Establishment of Patient-Derived Tumor Xenograft Models of High-Risk Endometrial Cancer". International Journal of Gynecologic Cancer 28, n.º 9 (novembro de 2018): 1812–20. http://dx.doi.org/10.1097/igc.0000000000001365.
Texto completo da fonteMatei, Daniela. "Abstract IA018: Epigenome targeting in ovarian cancer: preclinical models to clinic". Cancer Research 84, n.º 5_Supplement_2 (4 de março de 2024): IA018. http://dx.doi.org/10.1158/1538-7445.ovarian23-ia018.
Texto completo da fonteIaia, Ilenia, Loretta Gammaitoni, Giulia Cattaneo, Lidia Giraudo, Chiara Donini, Erika Fiorino, Luca Primo et al. "Recruitment, Infiltration, and Cytotoxicity of HLA-Independent Killer Lymphocytes in Three-Dimensional Melanoma Models". Cancers 13, n.º 10 (11 de maio de 2021): 2302. http://dx.doi.org/10.3390/cancers13102302.
Texto completo da fonteGrausam, Katie, David Rincon Fernandez Pacheco, Emily Hatanaka, Stephen Shiao e Joshua Breunig. "MODL-34. A SERIES OF EGFR-MUTANT MODELS OF GLIOBLASTOMA THAT RECAPITULATES PATIENT TUMOR HETEROGENEITY AND RESPONSE TO TREATMENT". Neuro-Oncology 25, Supplement_5 (1 de novembro de 2023): v306. http://dx.doi.org/10.1093/neuonc/noad179.1185.
Texto completo da fonteOdunsi, Adekunle, A. J. Robert McGray, Anthony Miliotto, Yali Zhang, Jianming Wang, Adebukola Abiola, Cheryl Eppolito e Ruea-Yea Huang. "Fidelity of human ovarian cancer patient-derived xenografts in a partially humanized mouse model for preclinical testing of immunotherapies". Journal for ImmunoTherapy of Cancer 8, n.º 2 (novembro de 2020): e001237. http://dx.doi.org/10.1136/jitc-2020-001237.
Texto completo da fonteFranklin, M., M. Thayer, D. Draper, D. Saims e S. Wise. "Preclinical assessment of anti-tumor activity and immune response in syngeneic tumor models". European Journal of Cancer 69 (dezembro de 2016): S97. http://dx.doi.org/10.1016/s0959-8049(16)32887-8.
Texto completo da fonte